Gü2602（Cat No.:I043704）is a small molecule compound that functions as a selective inhibitor of a specific target protein or enzyme involved in critical cellular processes such as signal transduction, immune response, or metabolism. It is primarily being researched for its potential therapeutic applications in cancer and autoimmune diseases. By inhibiting its target, Gü2602 may help modulate immune cell activity, reduce inflammation, and suppress tumor growth. Ongoing studies are focused on evaluating its safety, efficacy, and pharmacokinetics, with the goal of determining its clinical potential in the treatment of various diseases.